STAT1 and autoimmune disease: If the desired drug action was to inhibit the pathway response, e.g., in autoimmune diseases, p45 (ks1_phos in the original model—STAT1 phosphorylation rate) would be the parameter of choice, according to the ranking shown in Figure 8.